Alimera Sciences Акции в обращении
Что обозначает Акции в обращении в Alimera Sciences?
Акции в обращении Alimera Sciences Inc. является 54.384M
Какое определение для Акции в обращении?
Акции в обращении - это все акции корпорации или финансового актива, которые были разрешены, выпущены и приобретены инвесторами и находятся в их собственности.
Shares outstanding includes all stock held by investors including both common shares held by the public and restricted shares owned by the company's internal managements. Shares outstanding have rights and represent an ownership in the corporation by the person who holds the shares. They are distinguished from treasury shares, which are shares held by the corporation itself and have no exercisable rights. Shares outstanding plus treasury shares together amount to the number of issued shares.
Shares outstanding can be calculated as either basic or fully diluted. The basic count is the current number of shares. Dividend distributions and voting in the general meeting of shareholders are calculated according to this number. The fully diluted shares outstanding count, on the other hand, includes diluting securities, such as warrants, capital notes or convertibles. If the company has any diluting securities, this indicates the potential future increased number of shares outstanding. A company's market capitalization is calculated by multiplying the price of one of its shares by the total number outstanding shares a company has issued.
Акции в обращении компаний в Health Care сектор на NASDAQ по сравнению с Alimera Sciences
Что делает Alimera Sciences?
alimera, founded in june 2003, is a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals. alimera is presently focused on diseases affecting the back of the eye, or retina, because these diseases are not well treated with current therapies and will affect millions of people in aging populations. alimera's commitment to retina specialists and their patients is manifest in its product and in its development portfolio designed to treat early- and late-stage diseases. for more information, please visit www.alimerasciences.com. alimera's european operations are conducted from london by its subsidiary, alimera sciences limited.
Компании с акции в обращении похож на Alimera Sciences
- Lindblad Expeditions Inc имеет Акции в обращении из 54.319M
- BelaraRox Ltd имеет Акции в обращении из 54.330M
- NP3 Fastigheter AB (publ) имеет Акции в обращении из 54.339M
- Blackline Safety имеет Акции в обращении из 54.349M
- IPL Plastics имеет Акции в обращении из 54.382M
- Sol Cuisine Ltd имеет Акции в обращении из 54.382M
- Alimera Sciences имеет Акции в обращении из 54.384M
- 827013 имеет Акции в обращении из 54.385M
- Veritex Inc имеет Акции в обращении из 54.386M
- Smith & Wesson Brands имеет Акции в обращении из 54.389M
- Kudelski SA имеет Акции в обращении из 54.390M
- Galera Therapeutics Inc имеет Акции в обращении из 54.392M
- PIMCO Corporate & Income Strategy Fund имеет Акции в обращении из 54.406M